Figure 2.
Changes in left ventricle ejection fraction (LVEF) during the treatment. Compared to baseline, LVEF did not change during the chemotherapy with doxorubicin (p = 0.178).
Changes in left ventricle ejection fraction (LVEF) during the treatment. Compared to baseline, LVEF did not change during the chemotherapy with doxorubicin (p = 0.178).